DEXCOM INC (DXCM) Deferred State and Local Income Tax Expense (Benefit) USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Dexcom Inc annual/quarterly Deferred State and Local Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Dexcom Inc Deferred State and Local Income Tax Expense (Benefit) for the quarter ending December 31, 2017 was $0.000.
  • Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2023 was $14.6 M.
  • Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2022 was -$17.6 M, a 8700% decline from 2021.
  • Dexcom Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2021 was -$200 K, a 99.6% increase from 2020.
Deferred State and Local Income Tax Expense (Benefit), Annual (USD)
Deferred State and Local Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.6 M +$32.2 M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-08
2022 -$17.6 M -$17.4 M -8700% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-08
2021 -$200 K +$50.3 M +99.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-08
2020 -$50.5 M -$50.5 M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $0 +$500 K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-14
2018 -$500 K -$500 K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-11
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-02-13
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.